Q2 2014 Holdings
Filed 2014-08-14 | 64 holdings | $301.2M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Mylan Inc | COMMON | 628530107 | $76.3K | 1,479,982 | 0.0% |
| Alexion Pharmaceuticals Inc(ALXN) | COMMON | 015351109 | $76.4K | 489,108 | 0.0% |
| Teva Pharmaceutical(TEVA) | ADR | 881624209 | $79.3K | 1,512,587 | 0.0% |
| Incyte Corporation(INCY) | COMMON | 45337C102 | $88.7K | 1,571,452 | 0.0% |
| Vertex Pharmaceuticals Inc(VRTX) | COMMON | 92532F100 | $102.2K | 1,079,464 | 0.0% |
| Celgene Corp(CELG) | COMMON | 151020104 | $107.4K | 1,250,672 | 0.0% |
| Gilead Sciences Inc(GILD) | COMMON | 375558103 | $124.3K | 1,499,116 | 0.0% |
| Amgen Inc(AMGN) | COMMON | 031162100 | $141.5K | 1,195,165 | 0.0% |
| Accuray Inc(ARAY) | COMMON | 004397105 | $4.3M | 491,505 | 1.4% |
| Boston Scientific(BSX) | COMMON | 101137107 | $13.3M | 1,043,587 | 4.4% |
| Abbvie Inc(ABBV) | COMMON | 00287Y109 | $15.3M | 271,741 | 5.1% |
| Align Tech Inc(ALGN) | COMMON | 016255101 | $16.5M | 294,356 | 5.5% |
| Biomarin Pharmaceutical Inc(BMRN) | COMMON | 09061G101 | $72.7M | 1,168,504 | 24.1% |
| Biogen Idec Inc(BIIB) | COMMON | 09062X103 | $177.0M | 561,379 | 58.8% |